$0.46 -0.01 (-2.17%)
11/27/2009 11:07 AM

Cytomedix, Inc. (GTF)

CAPS Rating: No stars

A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.

Results 1 - 2 of 2

Recs

0
Member Avatar lobnews (27.33) Submitted: 10/30/2007 1:51:34 PM : Outperform Start Price: $3.97 GTF Score: -63.10

Seems interesting. spec play

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar SteadySaber (71.71) Submitted: 10/1/2007 7:01:11 PM : Outperform Start Price: $5.00 GTF Score: -65.05

FDA approval. CMS catalysts. Wide open market. This stock is worth more then $114 million.

Report this Post 0 Comments | Reply | Permalink
Results 1 - 2 of 2

Featured Broker Partners